Clinical Trial Update: Dose Response of a Tubule Occlusion Agent [Phase 4]

View source ↗

Summary

This document reports the completion and posting of results from Phase 4 dose-response studies of a tubule occlusion agent for dentine hypersensitivity and dent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Pain
• Dentine Hypersensitivity

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dentine Hypersensitivity, Dental Pain | Phase 4 | Status: COMPLETED | Results posted: 2013-06-03